AMINOCAPROIC ACID

Generic: AMINOCAPROIC ACID

Camber PharmaceuticalsManufacturer
ORALRoute
AMINOCAPROIC ACIDActive Substance
2022-11-04Original Approval

AMINOCAPROIC ACID is FDA application ANDA216464, sponsored by ANNORA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2026-07-24
AMINAOCAPROIC ACID INJECTION, USP, 250 mg/mL (5 g/20 mL), packaged in a) 20 mL MULTIPLE DOSE VIAL FOR IV INFUSION (NDC 0

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, gla

Top Reported Reactions

1
HAEMORRHAGE
129 reports
2
OFF LABEL USE
64 reports
3
DRUG INEFFECTIVE
51 reports
4
EPISTAXIS
49 reports
5
DEATH
37 reports
6
FALL
35 reports
7
HAEMARTHROSIS
33 reports
8
MOUTH HAEMORRHAGE
31 reports
9
PAIN
29 reports
10
HYPOTENSION
28 reports